Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
This page is not indexed by search engines while we improve data quality.
Littman Dan R — Physics
Littman Dan R holds 4 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Littman Dan R |
| Technology | Physics |
| Patents in slice | 4 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2018 |
Representative patents
Notable publications linking Littman Dan R to Physics.
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Recent filings
Latest patents from Littman Dan R in Physics.
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody
US-10160805-B2 · Dec 25, 2018 · US
Related pages
Navigate to parent entity pages.